Sihuan Pharmaceutical Holdings Group Profit Margin

Sihuan Pharmaceutical Holdings Group (SHPHF) currently reports a profit margin of 4.67% as of June 2026. That compares with -57.91% in the prior-year period — up 108.1% year over year. That is below the sector sector average of 13.09%. Use the charts on this page to explore Sihuan Pharmaceutical Holdings Group's profit margin history and peer comparisons.

Sihuan Pharmaceutical Holdings Group's profit margin increased from -57.91% to 4.67% — a 108.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sihuan Pharmaceutical Holdings Group's profit margin of 4.67% is lower than the its sector sector average of 13.09%. That is roughly 64.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Sihuan Pharmaceutical Holdings Group's current 4.67% should be judged against industry norms (sector average: 13.09%) and against SHPHF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 4.67%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.09%. From there, open related valuation or income-statement pages for Sihuan Pharmaceutical Holdings Group, and consider following SHPHF for alerts when major investors trade the stock.